Evidence map›Paper›PMID 39911748›Full record

ReviewIJID regions2025

Antimicrobial resistance burden estimates from the bottom-up: research priorities for estimating the impact of antimicrobial resistance in Brazil.

Katherine Keenan, Carlos Roberto Veiga Kiffer, Érico V S Carmo, Juliana Silva Corrêa, André Luiz de Abreu, Adriano Massuda, Ana Christina Gales, Arnaldo Lopes Colombo, Institute of Antimicrobial Resistance of São Paulo (ARIES) group

Abstract readReview
In one paragraph

Review in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katherine KeenanSchool of Geography and Sustainable Development, University of St Andrews, St Andrews, United Kingdom.
Carlos Roberto Veiga KifferEscola Paulista de Medicina - Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Érico V S CarmoEscola Paulista de Medicina - Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Juliana Silva CorrêaEscola de Administração de Empresas da Fundação Getúlio Vargas, São Paulo, Brazil.
André Luiz de AbreuSecretaria de Vigilância em Saúde, Ministério da Saúde (SVS/MS), Brasília-DF, Brazil.
Adriano MassudaEscola de Administração de Empresas da Fundação Getúlio Vargas, São Paulo, Brazil.
Ana Christina GalesEscola Paulista de Medicina - Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Arnaldo Lopes ColomboEscola Paulista de Medicina - Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Institute of Antimicrobial Resistance of São Paulo (ARIES) group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent estimates of deaths attributable to bacterial antimicrobial resistance (AMR) highlight the immense public health threat of AMR to healthcare systems, economies, and communities in Latin America. Although global modelling studies generate important statistics to motivate and guide global and national agendas, their complex methodology and aggregation mean that they have a more limited impact at the local scales where AMR is experienced and tackled. At the same time, it is increasingly recognised that we need to study and design AMR policies 'from the bottom-up', drawing on data and perspectives that ensure local ownership of the research and policy agenda. But how do we integrate 'bottom-up' perspectives into AMR burden estimation? Brazil is used as a case study to illustrate the importance of this approach. Brazil's vast and decentralised healthcare system would benefit from robust regional estimates of AMR's clinical, economic, and social burdens to move political decision-making and design appropriate interventions. We report on recommendations gathered from interdisciplinary stakeholder exercises and propose strategic priorities for estimating the AMR burden in Brazil at subnational scales of governance. These include focusing on individual-level data linkages at various scales; capturing public and private healthcare systems; understanding AMR inequalities; and capturing linked clinical, economic, and social burdens.

Indexed as

Antimicrobial resistanceBrazilClinical burdenPolicyStudy design

Identifiers

PMID39911748
PMCPMC11795537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.